New test could spare heartburn patients uncomfortable procedures

NCT ID NCT07437768

Summary

This study is testing if a stronger acid-blocking medicine called Vonoprazan can help doctors figure out why some people's heartburn and reflux symptoms don't get better with standard treatments. Researchers will give the medicine to 100 adults whose symptoms persist despite taking common acid reducers for at least 8 weeks. The goal is to see if a patient's response to this stronger medicine can help diagnose the cause of their symptoms, potentially avoiding more invasive tests.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REFRACTORY GERD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Fu Jen Catholic University Hospital

    New Taipei City, Taiwan, 24352, Taiwan

Conditions

Explore the condition pages connected to this study.